Qi Yu Chen is a Chinese businessperson who has been at the helm of 23 different companies and currently is Chairman of China Medical Pharmaceutical Material Association, Co-Chairman of New Frontier Health Corp., Chairman for Beijing Xingyuan Innovative Equity Investment Fund Mgmt Co, Chairman for Shanghai Fosun Pioneering Investment Mgmt Ltd., Chairman of Shanghai Xingshuangjian Medical Investment Mgmt Co., Ltd., Director & Vice Chairman at Luz Saúde SA, Chairman for Shanghai Fosun Pharmaceutical Development Co., Ltd., Chairman for Shanghai Fosun Pharmaceutical Co. Ltd., Chairman at Fosun Industrial Co., Ltd., Chairman of Shanghai Fusheng Pharmaceutical Technology Dev Co., Ltd., Chairman for Shanghai Fosun Chemical Pharm Venture Capital Co. Ltd., Chairman at Fosun Pharma Industrial Pte Ltd., Chairman at Shanghai Henlius Biotech, Inc. and Co-Chief Executive Officer & Executive Director at Fosun International Ltd. Mr. Chen is also Chairman at Shanghai Fosun High Technology (Group) Co., Ltd., Chairman for Shanghai Biopharmaceutical Industry Association and Vice Chief Commissioner at China Medicinal Biotech Association and on the board of 48 other companies. In the past Qi Yu Chen held the position of Chairman of Neng Yue Co., Ltd., Chairman for Shanghai Licensed Pharmacist Association and Chairman of Shanghai Pharmaceutical Industry Association. Mr. Chen received an undergraduate degree from Fudan University and an MBA from China Europe International Business School.